Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 160

Results For "VIT"

2129 News Found

First ever nationwide epidemiological diabetes study released
Healthcare | April 22, 2022

First ever nationwide epidemiological diabetes study released

Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications


Qvella FAST System and FAST-PBC get CE marked and USFDA listed
Biotech | April 22, 2022

Qvella FAST System and FAST-PBC get CE marked and USFDA listed

With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods


Saraq Hepatitis C kit receives CDSCO nod
Drug Approval | April 21, 2022

Saraq Hepatitis C kit receives CDSCO nod

The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth


CK Birla Hospital performs highest number of VABB surgeries in a year
Hospitals | April 21, 2022

CK Birla Hospital performs highest number of VABB surgeries in a year

Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress


Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug
Drug Approval | April 20, 2022

Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug

Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA


India Health Link join hands with U GRO Capital
Healthcare | April 20, 2022

India Health Link join hands with U GRO Capital

U GRO Capital is a listed MSME lending fintech platform


Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon
Biotech | April 19, 2022

Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon

By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)


Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India
News | April 19, 2022

Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India

Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer


Bollywood actor Sonu Sood joins hands with Aster Volunteers to raise awareness on liver disease
Hospitals | April 19, 2022

Bollywood actor Sonu Sood joins hands with Aster Volunteers to raise awareness on liver disease

Through the association, Aster Volunteers would support 50 children from underprivileged families undergo liver transplants at Aster CMI and Aster RV Hospitals in Bangalore, and Aster Medcity and Aster MIMS Hospital Calicut in Kerala, India


Akron Bio completes plasmid DNA manufacturing facility
News | April 19, 2022

Akron Bio completes plasmid DNA manufacturing facility

The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets